.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
AstraZeneca
Chubb
Dow
UBS
Julphar
Colorcon
Queensland Health
Express Scripts
Farmers Insurance

Generated: September 19, 2017

Patent: ► Subscribe

Summary for Patent: ► Subscribe

Title:Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
Abstract: The present invention is directed to protocells for specific targeting of hepatocellular and other cancer cells which comprise a nanoporous silica core with a supported lipid bilayer; at least one agent which facilitates cancer cell death (such as a traditional small molecule, a macromolecular cargo (e.g. siRNA or a protein toxin such as ricin toxin A-chain or diphtheria toxin A-chain) and/or a histone-packaged plasmid DNA disposed within the nanoporous silica core (preferably supercoiled in order to more efficiently package the DNA into protocells) which is optionally modified with a nuclear localization sequence to assist in localizing protocells within the nucleus of the cancer cell and the ability to express peptides involved in therapy (apoptosis/cell death) of the cancer cell or as a reporter, a targeting peptide which targets cancer cells in tissue to be treated such that binding of the protocell to the targeted cells is specific and enhanced and a fusogenic peptide that promotes endosomal escape of protocells and encapsulated DNA. Protocells according to the present invention may be used to treat cancer, especially including hepatocellular (liver) cancer using novel binding peptides (c-MET peptides) which selectively bind to hepatocellular tissue or to function in diagnosis of cancer, including cancer treatment and drug discovery.
Inventor(s): Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM)
Assignee: STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM)
Application Number:14/113,371
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Schering
INTRON A
interferon alfa-2b
VIAL1031320011986-06-04► Subscribe STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) ► SubscribeRXsearch
Schering
INTRON A
interferon alfa-2b
VIAL1031320021986-06-04► Subscribe STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) ► SubscribeRXsearch
Schering
INTRON A
interferon alfa-2b
VIAL1031320031986-06-04► Subscribe STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) ► SubscribeRXsearch
Amgen
EPOGEN/PROCRIT
epoetin alfa
VIAL; SINGLE-USE1032340011989-06-01► Subscribe STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) ► SubscribeRXsearch
Amgen
EPOGEN/PROCRIT
epoetin alfa
VIAL; MULTIDOSE1032340021989-06-01► Subscribe STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) ► SubscribeRXsearch
Amgen
EPOGEN/PROCRIT
epoetin alfa
VIAL; MULTIDOSE1032340031989-06-01► Subscribe STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) ► SubscribeRXsearch
Amgen
EPOGEN/PROCRIT
epoetin alfa
VIAL; SINGLE-USE1032340041989-06-01► Subscribe STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) ► SubscribeRXsearch
Amgen
EPOGEN/PROCRIT
epoetin alfa
VIAL; SINGLE-USE1032340051989-06-01► Subscribe STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) ► SubscribeRXsearch
Amgen
EPOGEN/PROCRIT
epoetin alfa
VIAL; SINGLE-USE1032340061989-06-01► Subscribe STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) ► SubscribeRXsearch
Amgen
EPOGEN/PROCRIT
epoetin alfa
VIAL; SINGLE-USE1032340071989-06-01► Subscribe STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) ► SubscribeRXsearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Summary for Patent: ► Subscribe

PCT Information
PCT FiledApril 27, 2012PCT Application Number:PCT/US2012/035529
PCT Publication Date:November 01, 2012PCT Publication Number: WO2012/149376

International Patent Family for Patent: ► Subscribe

Country Document Number Publication Date
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Fish and Richardson
Baxter
Express Scripts
McKesson
Queensland Health
Cerilliant
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot